Elementis

Photo

Elementis Plans New R&D Unit in Portugal

UK’s Elementis, a global specialty chemicals company, will be opening a new unit in Portugal, featuring a center of excellence and R&D laboratory. The new unit, which will be headquartered in Porto and is scheduled to open in the first half of 2024, will support the company’s business segments Personal Care and Performance Specialties and also reinforce the current R&D capacity of the Elementis' laboratories in Asia and the Americas.

Photo

Elementis to Sell Chromium Business to Yildirim

UK specialty chemicals company Elementis has agreed to sell its chromium business to the Yildirim Group for $170 million. The deal values the business at 7.3 times the EBITDA posted in fiscal 2022 (30 June.)

Photo

Elementis Rebuffs Innospec Approach

UK specialty chemicals company Elementis has been the subject of another attempted takeover – its fourth in under six months – but this time from US rival, Innospec.

Photo

Elementis Rejects Minerals’ Third Offer

Undeterred by the rejection of its two previous offers, Minerals Technologies submitted a revised and third proposal on Dec. 4 to take over UK specialty chemicals company Elementis.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.